Compare CRL & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | HRL |
|---|---|---|
| Founded | 1947 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 11.8B |
| IPO Year | 1999 | 1994 |
| Metric | CRL | HRL |
|---|---|---|
| Price | $293.36 | $19.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $198.27 | $26.50 |
| AVG Volume (30 Days) | 827.6K | ★ 4.0M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 5.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $1,857,601,000.00 | ★ $12,106,160,000.00 |
| Revenue This Year | N/A | $2.66 |
| Revenue Next Year | $3.04 | $1.62 |
| P/E Ratio | ★ N/A | $27.54 |
| Revenue Growth | ★ 10.48 | 1.55 |
| 52 Week Low | $145.47 | $19.69 |
| 52 Week High | $303.31 | $26.60 |
| Indicator | CRL | HRL |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 21.73 |
| Support Level | $267.27 | N/A |
| Resistance Level | $303.31 | $26.37 |
| Average True Range (ATR) | 9.37 | 0.42 |
| MACD | 0.17 | -0.03 |
| Stochastic Oscillator | 86.35 | 8.41 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.